|
Business Outline
The Companys unique organic synthetic technology precisely satisfies
pharmaceutical industry demand with the development and marketing of essential
bases, intermediates and additives. The Company was the first to establish
mass production technology for AOSA (acetoxyazetidinone), an intermediate
for penem and carbapenem antibiotics. We also originated joint development
with Suntory Ltd. and Yamanouchi Pharmaceutical Co., Ltd. of the worlds
first oral penem antibiotic, FAROPENEM-Sodium, and supplies the base for
this biotic. The Company also succeeded at mass production of piperazine
amid and supplies that component of anti-HIV drugs to Merck Inc. of the
U.S., and is Japans only company to produce HPC (hydroxy propyl cellulose),
an additive used in the manufacture of pharmaceuticals.
Main Products
Pharmaceuticals & Intermediates
DAMN (diaminomaleonitril)
PDC (pyrazine-2, 3-dicarboxylic acid)
AOSA (a key intermediate for newer generation antibiotics)
NISSO-HPC (hydroxypropyl cellulose)
FAROPENEM-Sodium
MAP
|